The safety of liposome bupivacaine, a novel local analgesic formulation.
about
Liposomal bupivacaine infiltration into the transversus abdominis plane for postsurgical analgesia in open abdominal umbilical hernia repair: results from a cohort of 13 patientsThe safety of liposome bupivacaine following various routes of administration in animals.Retrospective analysis of quality improvement when using liposome bupivacaine for postoperative pain control.An extended paIn relief trial utilizing the infiltration of a long-acting Multivesicular liPosome foRmulation Of bupiVacaine, EXPAREL (IMPROVE): a Phase IV health economic trial in adult patients undergoing ileostomy reversal.Liposome bupivacaine (EXPAREL®) for extended pain relief in patients undergoing ileostomy reversal at a single institution with a fast-track discharge protocol: an IMPROVE Phase IV health economics trialLiposomal extended-release bupivacaine for postsurgical analgesiaA Content Incontinent: Report of Liposomal Bupivacaine Induced Fecal Incontinence.Liposome Bupivacaine for Postsurgical Analgesia in Adult Patients Undergoing Laparoscopic Colectomy: Results from Prospective Phase IV Sequential Cohort Studies Assessing Health Economic Outcomes.Time to Analgesia Onset and Pharmacokinetics After Separate and Combined Administration of Liposome Bupivacaine and Bupivacaine HCl: Considerations for Clinicians.Long Acting Liposomal Bupivacaine for Percutaneous Sympathetic Stellate Ganglion Blockade: A Technical Note.Drug delivery systems for prolonged duration local anesthesia.Liposomal Bupivacaine Use in Third Molar Impaction Surgery: INNOVATE Study.Real-world insights on the use of transversus abdominis plane block with liposomal bupivacaine in the multimodal management of somatic versus visceral pain in the colorectal surgery setting.Pain relief after ambulatory surgery: Progress over the last decade
P2860
Q34090031-C59676C6-2DE5-4CEA-85DD-EF457BC5B3BBQ36253236-CAAB96E6-A599-441E-92EE-7BAD3E9ABD65Q36843184-CF339E62-297C-47CA-926D-B18C9A63F2DDQ37038343-0A7E5F3C-9F9D-4925-B344-09B99ACCD111Q37075057-BF42AA88-85B1-44E5-B11A-5D887C1A296EQ37169985-6C4B6339-E794-4509-9266-D0CA418711A0Q37322591-391AA272-12D2-4468-AEA1-79627A17FFC2Q37715502-8B0533C2-CF88-454B-8694-6B2D0B10C9B5Q39652976-37BEE356-F0B4-43C6-BEB0-87EE30ABF65FQ44562033-260E58DB-6CB8-4032-9E7C-EA5C4D4F5378Q47100619-895ED459-8238-46E1-9F1A-00063E4AD1DDQ50246093-D85408CB-A7CA-466D-A738-139A2D70AF33Q55387486-88243D74-506E-40ED-8B5E-5E180831041BQ59138508-A209570F-D56C-4864-9B41-1079F86F363A
P2860
The safety of liposome bupivacaine, a novel local analgesic formulation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
The safety of liposome bupivacaine, a novel local analgesic formulation.
@en
The safety of liposome bupivacaine, a novel local analgesic formulation.
@nl
type
label
The safety of liposome bupivacaine, a novel local analgesic formulation.
@en
The safety of liposome bupivacaine, a novel local analgesic formulation.
@nl
prefLabel
The safety of liposome bupivacaine, a novel local analgesic formulation.
@en
The safety of liposome bupivacaine, a novel local analgesic formulation.
@nl
P2093
P1476
The safety of liposome bupivacaine, a novel local analgesic formulation.
@en
P2093
Eugene R Viscusi
Raymond Sinatra
Sonia L Ramamoorthy
P304
P356
10.1097/AJP.0B013E318288E1F6
P407
P577
2014-02-01T00:00:00Z